Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Scientists at La Trobe University have identified a possible defense for humans against the influenza virus H5N1—commonly ...

Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell ...

Immune cells might be reprogrammed to use the body’s fructose — a naturally occurring sugar — as an energy source that supercharges them to fight cancer, researchers at Memorial Sloan Kettering Cancer ...

What recent advancements in CAR T-cell therapy are you most excited about, especially in treating lymphomas? The advancements in CAR T-cell therapy, particularly for treating lymphomas ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).

A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, 'CARsgen Therapeutics'), a company focused on innovative CAR ...

Aim to accelerate clinical timelines, reduce manufacturing bottlenecks, and enhance scalability, to bring Swarm's T cell ...